JP2011507845A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507845A5
JP2011507845A5 JP2010539469A JP2010539469A JP2011507845A5 JP 2011507845 A5 JP2011507845 A5 JP 2011507845A5 JP 2010539469 A JP2010539469 A JP 2010539469A JP 2010539469 A JP2010539469 A JP 2010539469A JP 2011507845 A5 JP2011507845 A5 JP 2011507845A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
surgical treatment
brimonidine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010539469A
Other languages
English (en)
Japanese (ja)
Other versions
JP5580210B2 (ja
JP2011507845A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/013797 external-priority patent/WO2009082452A1/en
Publication of JP2011507845A publication Critical patent/JP2011507845A/ja
Publication of JP2011507845A5 publication Critical patent/JP2011507845A5/ja
Application granted granted Critical
Publication of JP5580210B2 publication Critical patent/JP5580210B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010539469A 2007-12-21 2008-12-17 手術前治療 Expired - Fee Related JP5580210B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1591207P 2007-12-21 2007-12-21
US61/015,912 2007-12-21
PCT/US2008/013797 WO2009082452A1 (en) 2007-12-21 2008-12-17 Pre-surgical treatment

Publications (3)

Publication Number Publication Date
JP2011507845A JP2011507845A (ja) 2011-03-10
JP2011507845A5 true JP2011507845A5 (enExample) 2012-02-16
JP5580210B2 JP5580210B2 (ja) 2014-08-27

Family

ID=40801507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010539469A Expired - Fee Related JP5580210B2 (ja) 2007-12-21 2008-12-17 手術前治療

Country Status (10)

Country Link
US (1) US20110224215A1 (enExample)
EP (1) EP2230910A4 (enExample)
JP (1) JP5580210B2 (enExample)
KR (1) KR20100099191A (enExample)
CN (1) CN101902913B (enExample)
AU (1) AU2008341112B2 (enExample)
BR (1) BRPI0822095A2 (enExample)
CA (1) CA2709199A1 (enExample)
NZ (1) NZ586302A (enExample)
WO (1) WO2009082452A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US20090061020A1 (en) * 2007-08-31 2009-03-05 Theobald Klaus P Brimonidine Compositions for Treating Erythema
PT2818184T (pt) * 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura
US20120295914A1 (en) * 2009-05-29 2012-11-22 Galderma Research & Development Combination of adrenergic receptor agonist alpha-1 or alpha-2, preferably brimonidine with fillers, preferably hyaluronic acid
WO2011117378A2 (en) * 2010-03-26 2011-09-29 Galderma Research & Development Improved methods and compositions for safe and effective treatment of telangiectasia
CN103298472A (zh) 2010-03-26 2013-09-11 盖尔德马研究及发展公司 安全和有效治疗红斑的改进的方法和组合物
FR2966366B1 (fr) * 2010-10-21 2012-11-09 Galderma Sa Composition de gel de brimonidine
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
FR2966365B1 (fr) * 2010-10-21 2012-11-09 Galderma Sa Composition de gel topique
ES2498217T5 (es) * 2010-10-21 2018-03-19 Galderma S.A. Composición en forma de gel basada en brimonidina
RU2013123043A (ru) * 2010-10-21 2014-12-10 Галдерма С.А. Гелевая композиция для местного применения
FR2977493B1 (fr) * 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
WO2013057579A2 (en) 2011-10-19 2013-04-25 Galderma Pharma S.A. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
JP6339364B2 (ja) * 2013-12-27 2018-06-06 カズマパートナーズ株式会社 無定形ブリモニジン酒石酸塩及びその製造方法
WO2019083771A1 (en) * 2017-10-23 2019-05-02 Microcures, Inc. METHOD FOR IMPROVING THE RECOVERY OF A SKIN TREATED WITH A COSMETIC LASER

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2003198C (en) 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5736165A (en) 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US6194415B1 (en) 1995-06-28 2001-02-27 Allergan Sales, Inc. Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
CA2154979A1 (en) * 1995-07-28 1997-01-29 Kenneth T. Armstrong Topical phenylephrine preparation
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US6294553B1 (en) * 2000-02-15 2001-09-25 Allergan Sales, Inc. Method for treating ocular pain
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
PT2818184T (pt) * 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura

Similar Documents

Publication Publication Date Title
RU2707254C1 (ru) Водный фармацевтический препарат и способ лечения хронической язвы
Barret et al. Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program
CN104307032B (zh) 一种止痛、抗菌、止血并促进伤口愈合的液体敷料
JP2019513136A5 (enExample)
WO2017011982A1 (zh) 贻贝粘蛋白产品及其抑制皮肤炎症的应用
CA2931564C (en) Composition, system and method for treating skin
JP2017514866A5 (enExample)
Abboud et al. Do silver-based wound dressings reduce pain? A prospective study and review of the literature
EP3013376A1 (en) Method of reducing scarring
RU2015146679A (ru) Тетрапептиды, полученные из с-х-с-хемокинов человека, подходящие для лечения различных состояний кожи
CN101879324A (zh) 壳聚糖复合医用敷料的制备方法
RU2009107068A (ru) Применение пропиленгликоля при лечении связанных с воспалением местных нарушений или заболеваний и ран
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
RU2423118C1 (ru) Способ лечения трофических язв
CN104906029A (zh) 一种鼻腔制剂及其制备方法和应用
CN102058456B (zh) 功能性自粘绷带
CN104490760B (zh) 辣椒碱‑胶原蛋白海绵的制备方法及其应用
CN102988277A (zh) 一种治疗皮肤疣、甲真菌病和胼胝等皮肤病的油膏
JP5796728B1 (ja) 創傷治癒を促進し生体諸臓器の被覆（コーチング）及び庇護を目的とした生体皮膜剤。
CN201939594U (zh) 功能性自粘绷带
TWI610674B (zh) 一種用於促進傷口癒合或預防、減少傷口疤痕生成的醫藥組合物
US20150086529A1 (en) Therapeutic Burn Gel
KR101820519B1 (ko) 설글리코타이드의 피부 상처 치유 촉진 용도, 및 이를 포함하는 외용제 조성물
CN104474577A (zh) 一种激光美容术后敷料及制备方法
CN104707164B (zh) 一种复合壳聚糖水凝胶敷料及其制备方法和应用